Brief Article
Copyright ©2010 Baishideng.
World J Gastroenterol. Jul 7, 2010; 16(25): 3168-3177
Published online Jul 7, 2010. doi: 10.3748/wjg.v16.i25.3168
Table 1 Demographic data of IBD patients and healthy controls, separated into CD and UC groups
DemographicsCDUC
Total179155
Age, mean, (SD), [range], yr38.9 (± 11.6) [18-71.6]39.8 (± 13.7) [18.6-75.5]
Age at disease onset, mean, (median), [interquartile range], yr28 (24.5) [14]31.6 (29.2) [16.2]
Age in males28.9 (± 11.7) [12.6-70.7]32.6 (± 12.2) [10.3-66.7]
Age in females27.5 (± 12.0) [6.2-72.9]30.6 (± 12.6) [11.8-70.6]
Gender, n (%)
Male71 (39.6%)71 (45.8%)
Female108 (60.3%)84 (54.2%)
IBD
Disease duration mean, (median), [inter quartile range], yr10.9 (9.2) [12.8]8.4 (6.7) [9.9]
Extraintestinal manifestations
Arthralgia10279
Uveitis62
Primary sclerosing cholangitis05
Pyoderma gangraenosum23
Erythema nodosum30
Autoimmune hepatitis01
Autoimmune hemolytic anemia01
CD-associated polyneuropathy1-
Pulmonary manifestations10
Current medication (% of users)
Prednisolone
Total37.741.3
Systemic25.732.7
Local13.711.3
Local and systemic1.72.7
5-Aminosalicylates
Total26.370.7
Local1.13.3
Immunosuppressants
Total54.930.0
Azathioprine/6-mercaptopurine46.926.4
6-MP2.94.0
Methotrexate2.31.3
Tacrolimus0.64.0
TNF-α-inhibitors9.10.7
Analgesics
Total29.120.7
No information25.132.7
Mean IBD severity, mean, (median), [interquartile range]
CDAI173 (166) [186]
CAI5.08 (4.5) [5]
SIBDQ, mean, (median), [interquartile range]48.3 (49) [21]46.7 (47) [21]
Males49.6 (51) [25]48.9 (48) [22]
Females47.4 (48) [19]44.5 (45) [19]
SIBDQ healthy controls58.5 (59) [10]